An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
The development of vaccines is one of the most significant medical accomplishments which has helped to eradicate a large number of diseases. It has undergone an evolutionary process from live attenuated pathogen vaccine to killed whole organisms or inactivated toxins (toxoids), each of them having i...
Main Authors: | Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, Kan Kaneko, Krutika K. Sawant, Nitesh K. Kunda, Imran Y. Saleem |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/4/455 |
Similar Items
-
In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives
by: Yarong Zeng, et al.
Published: (2023-12-01) -
Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives
by: Ali Nazarizadeh, et al.
Published: (2022-04-01) -
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
by: Abdellatif Bouazzaoui, et al.
Published: (2021-01-01) -
Exploring the possible use of saponin adjuvants in COVID-19 vaccine
by: Rinku Sharma, et al.
Published: (2020-12-01) -
Overview of vaccine adjuvants
by: Zhenchuan Wu, et al.
Published: (2021-09-01)